{"id":4113,"date":"2023-05-17T14:20:05","date_gmt":"2023-05-17T18:20:05","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=4113"},"modified":"2026-04-13T15:03:41","modified_gmt":"2026-04-13T19:03:41","slug":"why-should-neoventures-develop-your-aptamers","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/why-should-neoventures-develop-your-aptamers\/","title":{"rendered":"Pourquoi NeoVentures devrait-il d\u00e9velopper vos aptam\u00e8res?"},"content":{"rendered":"<p>NeoVentures est le leader mondial du d\u00e9veloppement d'aptam\u00e8res car nous avons dirig\u00e9 et continuons de diriger des am\u00e9liorations du processus de d\u00e9veloppement d'aptam\u00e8res. Au cours des deux derni\u00e8res ann\u00e9es, nous avons r\u00e9invent\u00e9 le d\u00e9veloppement d'aptam\u00e8res car cela \u00e9tait n\u00e9cessaire.<\/p>\n<h2>Aptam\u00e8res pour les diagnostics et les th\u00e9rapeutiques<\/h2>\n<p>Les clients utilisant des aptam\u00e8res \u00e0 des fins de diagnostic ou de th\u00e9rapie constataient que les aptam\u00e8res ne fonctionnaient pas aussi bien dans les fluides biologiques que les anticorps. Il y avait un faible niveau de r\u00e9activit\u00e9 crois\u00e9e avec des prot\u00e9ines abondantes comme l'albumine s\u00e9rique et IgG. La raison en est qu'avec le d\u00e9veloppement des anticorps, il existe un processus appel\u00e9 tol\u00e9rance immunitaire, selon lequel tout anticorps qui se lie \u00e0 une mol\u00e9cule du soi est \u00e9limin\u00e9. Cela n'existe pas dans le d\u00e9veloppement des aptam\u00e8res. Nous pensions que nous pourrions y parvenir en effectuant une contre-s\u00e9lection contre ces cibles, mais cela n'est pas aussi efficace que la tol\u00e9rance immunitaire. La contre-s\u00e9lection fonctionne bien pour \u00e9liminer les aptam\u00e8res qui se lient fortement \u00e0 la cible de contre, mais cela ne fonctionne pas aussi bien pour \u00e9liminer les aptam\u00e8res qui se lient faiblement \u00e0 la cible de contre.<\/p>\n<p>Les clients constataient que m\u00eame s'ils ne d\u00e9tectaient pas de liaison \u00e0 ces prot\u00e9ines abondantes, il devait y avoir un faible niveau de r\u00e9activit\u00e9 crois\u00e9e. \u00c9tant donn\u00e9 que l'albumine s\u00e9rique est pr\u00e9sente dans le plasma humain \u00e0 une concentration d'environ 600 \u00b5M, si la prot\u00e9ine cible du client est pr\u00e9sente \u00e0 une concentration de 600 pM, il est n\u00e9cessaire d'obtenir une sp\u00e9cificit\u00e9 d'un million de fois. Cela existe pour les anticorps en raison de la tol\u00e9rance immunitaire, mais cela n'existait pas pour les aptam\u00e8res que les gens essayaient de commercialiser.<\/p>\n<h2>La m\u00e9thode de s\u00e9lection Neomer<\/h2>\n<p>Pour surmonter cette contrainte, nous avons d\u00e9velopp\u00e9 une nouvelle m\u00e9thode de s\u00e9lection des aptam\u00e8res que nous appelons NEOMERS. En essence, la puissance de cette nouvelle m\u00e9thode r\u00e9side dans le fait que nous utilisons une biblioth\u00e8que des m\u00eames 4,29 milliards de s\u00e9quences contre chaque cible. Nous avons d\u00e9velopp\u00e9 une m\u00e9thode qui nous permet de caract\u00e9riser la r\u00e9ponse de chacune de ces s\u00e9quences \u00e0 n'importe quelle cible donn\u00e9e. Nous utilisons cela pour identifier les 10 000 meilleures s\u00e9quences pour une cible. Ensuite, nous identifions parmi ces 10 000 s\u00e9quences celles qui ne pr\u00e9sentent aucune r\u00e9ponse du tout \u00e0 l'albumine s\u00e9rique ou \u00e0 l'IgG.<\/p>\n<h2>Aptam\u00e8res pour les petites mol\u00e9cules : FRELEX<\/h2>\n<p>Avec notre approche brevet\u00e9e FRELEX, nous sommes l'entreprise leader en ce qui concerne les aptam\u00e8res pour les petites mol\u00e9cules. Les aptam\u00e8res que nous avons d\u00e9velopp\u00e9s pour les mycotoxines restent les meilleurs aptam\u00e8res jamais d\u00e9couverts pour les petites mol\u00e9cules. Avec notre approche NEOMER, nous sommes d\u00e9sormais le choix logique pour toute personne int\u00e9ress\u00e9e par les aptam\u00e8res pour les prot\u00e9ines. Nous avons d\u00e9velopp\u00e9 de nombreux aptam\u00e8res pour la d\u00e9tection des prot\u00e9ines transmembranaires sur les cellules vivantes, des aptam\u00e8res qui induisent l'endocytose pour une administration cibl\u00e9e de m\u00e9dicaments, et des aptam\u00e8res qui se lient mais n'induisent pas l'endocytose pour la pr\u00e9vention de l'infection virale.<\/p>\n<p>Nos m\u00e9thodes sont brevet\u00e9es et exclusives, ce qui signifie que nous sommes la seule entreprise capable de vous fournir le niveau de sp\u00e9cificit\u00e9 n\u00e9cessaire. Si il est possible de d\u00e9velopper un aptam\u00e8re pour une cible, alors nous sommes la meilleure entreprise pour le faire. Si ce n'est pas r\u00e9alisable, nous informerons nos clients que ce n'est pas possible. Nos aptam\u00e8res ont le niveau de sp\u00e9cificit\u00e9 n\u00e9cessaire pour que vous puissiez r\u00e9ussir \u00e0 les utiliser dans vos applications.<\/p>\n<p>En apprendre davantage en prenant contact avec notre \u00e9quipe d\u00e8s aujourd'hui. <a href=\"https:\/\/neoaptamers.com\/fr\/contact-us\/\">Contactez-nous sur notre site web d\u00e8s maintenant.<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>NeoVentures is the leader for aptamer development globally because we have led and are continuing to lead with improvements to the aptamer development process. Over the past two years, we have reinvented aptamer development because this was needed. Aptamers for Diagnostics and Therapeutics Clients using aptamers for diagnostic or therapeutic applications were finding that the&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/why-should-neoventures-develop-your-aptamers\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">Pourquoi NeoVentures devrait-il d\u00e9velopper vos aptam\u00e8res?<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":4114,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[12],"tags":[],"class_list":["post-4113","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamer-commercialization"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Why Should NeoVentures Develop Your Aptamers?<\/title>\n<meta name=\"description\" content=\"Choosing the right company to develop your aptamers is key to your application&#039;s success. Learn why NeoVentures is the best aptamer company.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/why-should-neoventures-develop-your-aptamers\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Should NeoVentures Develop Your Aptamers?\" \/>\n<meta property=\"og:description\" content=\"Choosing the right company to develop your aptamers is key to your application&#039;s success. Learn why NeoVentures is the best aptamer company.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/why-should-neoventures-develop-your-aptamers\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-17T18:20:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T19:03:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/05\/Images-for-Neomers.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"750\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Why Should NeoVentures Develop Your Aptamers?\",\"datePublished\":\"2023-05-17T18:20:05+00:00\",\"dateModified\":\"2026-04-13T19:03:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/\"},\"wordCount\":532,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Images-for-Neomers.png\",\"articleSection\":[\"Aptamer commercialization\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/\",\"name\":\"Why Should NeoVentures Develop Your Aptamers?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Images-for-Neomers.png\",\"datePublished\":\"2023-05-17T18:20:05+00:00\",\"dateModified\":\"2026-04-13T19:03:41+00:00\",\"description\":\"Choosing the right company to develop your aptamers is key to your application's success. Learn why NeoVentures is the best aptamer company.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Images-for-Neomers.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Images-for-Neomers.png\",\"width\":1000,\"height\":750,\"caption\":\"Close up photo of a microscope\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-should-neoventures-develop-your-aptamers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Should NeoVentures Develop Your Aptamers?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pourquoi NeoVentures devrait-il d\u00e9velopper vos aptam\u00e8res?","description":"Choosing the right company to develop your aptamers is key to your application's success. Learn why NeoVentures is the best aptamer company.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/why-should-neoventures-develop-your-aptamers\/","og_locale":"fr_FR","og_type":"article","og_title":"Why Should NeoVentures Develop Your Aptamers?","og_description":"Choosing the right company to develop your aptamers is key to your application's success. Learn why NeoVentures is the best aptamer company.","og_url":"https:\/\/neoaptamers.com\/fr\/why-should-neoventures-develop-your-aptamers\/","og_site_name":"neoaptamers","article_published_time":"2023-05-17T18:20:05+00:00","article_modified_time":"2026-04-13T19:03:41+00:00","og_image":[{"width":1000,"height":750,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/05\/Images-for-Neomers.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Why Should NeoVentures Develop Your Aptamers?","datePublished":"2023-05-17T18:20:05+00:00","dateModified":"2026-04-13T19:03:41+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/"},"wordCount":532,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/05\/Images-for-Neomers.png","articleSection":["Aptamer commercialization"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/","url":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/","name":"Pourquoi NeoVentures devrait-il d\u00e9velopper vos aptam\u00e8res?","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/05\/Images-for-Neomers.png","datePublished":"2023-05-17T18:20:05+00:00","dateModified":"2026-04-13T19:03:41+00:00","description":"Choosing the right company to develop your aptamers is key to your application's success. Learn why NeoVentures is the best aptamer company.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/05\/Images-for-Neomers.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/05\/Images-for-Neomers.png","width":1000,"height":750,"caption":"Close up photo of a microscope"},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/why-should-neoventures-develop-your-aptamers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Why Should NeoVentures Develop Your Aptamers?"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=4113"}],"version-history":[{"count":2,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4113\/revisions"}],"predecessor-version":[{"id":4116,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4113\/revisions\/4116"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/4114"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=4113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=4113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=4113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}